Pizzuti Dana

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$4.14M

Insider Activity of Pizzuti Dana

According to the SEC Form 4 filings, Pizzuti Dana, being in a position of

  1. Chief Med and Dev Officer at Crinetics Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 82089 shares for $3.67M,
    over all time since 2023-04-05, has bought 0 shares, and sold 99884 shares for $4.14M.

The largest sale of all time was on 2024-10-03 and amounted to 14375 shares of Crinetics Pharmaceuticals, Inc. for $785,306.

Biography of Pizzuti Dana

No biography is available at this moment.

2024-10-03SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Med and Dev Officer
14,375
0.0194%
$54.63$785,306+7.43%
2024-07-03SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Med and Dev Officer
14,375
0.0194%
$44.87$645,0060%
2024-06-24SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Med and Dev Officer
9,500
0.0121%
$45.73$434,435+17.91%
2024-04-15SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Med and Dev Officer
14,375
0.0188%
$44.47$639,256+19.15%
2024-03-20SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Med and Dev Officer
15,089
0.0188%
$44.06$664,763+12.28%
2024-01-03SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Med and Dev Officer
14,375
0.0216%
$35.00$503,125+36.28%
2023-12-21SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Med and Dev Officer
9,583
0.0143%
$34.57$331,284+35.41%
2023-04-05SaleCrinetics Pharmaceuticals, Inc.
CRNX
Chief Development Officer
8,212
0.0154%
$16.15$132,624+78.51%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.